Go Pro

Northland Securities Decreases Earnings Estimates for inTEST

inTEST logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Northland Securities lowered its FY2030 earnings estimate for inTEST to $1.18 per share from $1.28, while maintaining an “Outperform” rating and a $15 price target.
  • Analyst sentiment remains generally positive, with inTEST holding a consensus “Moderate Buy” rating and an average target price of $17, despite Zacks Research downgrading the stock to “Hold.”
  • inTEST shares were trading down 6.0% at $13.21, while institutional investors owned 63.18% of the company’s stock.
  • MarketBeat previews the top five stocks to own by September 1st.

inTEST Co. (NYSE:INTT - Free Report) - Research analysts at Northland Securities decreased their FY2030 earnings estimates for shares of inTEST in a research report issued on Monday, August 10th. Northland Securities analyst T. Jackson now anticipates that the company will post earnings of $1.18 per share for the year, down from their previous forecast of $1.28. Northland Securities has a "Outperform" rating and a $15.00 price objective on the stock. The consensus estimate for inTEST's current full-year earnings is $0.41 per share.

Separately, Zacks Research lowered shares of inTEST from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 3rd. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $17.00.

Read Our Latest Analysis on inTEST

inTEST Trading Down 6.0%

Shares of NYSE INTT opened at $13.21 on Tuesday. The firm has a market capitalization of $165.98 million, a PE ratio of 57.44 and a beta of 1.51. inTEST has a one year low of $6.63 and a one year high of $20.00. The company has a current ratio of 2.26, a quick ratio of 1.38 and a debt-to-equity ratio of 0.08. The business has a 50-day moving average price of $15.44 and a two-hundred day moving average price of $14.48.

Institutional Investors Weigh In On inTEST

A number of large investors have recently bought and sold shares of INTT. Ritholtz Wealth Management acquired a new stake in inTEST in the 4th quarter worth approximately $267,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of inTEST during the 1st quarter worth $1,275,000. Globeflex Capital L P grew its stake in inTEST by 632.6% in the 1st quarter. Globeflex Capital L P now owns 118,572 shares of the company's stock valued at $1,619,000 after buying an additional 102,387 shares during the last quarter. Royce & Associates LP raised its holdings in inTEST by 7.3% in the 4th quarter. Royce & Associates LP now owns 1,555,020 shares of the company's stock worth $11,616,000 after acquiring an additional 106,222 shares during the period. Finally, Walleye Capital LLC acquired a new position in inTEST during the 1st quarter worth $953,000. 63.18% of the stock is currently owned by institutional investors.

About inTEST

(Get Free Report)

inTEST Corporation NYSE: INTT is a developer and manufacturer of precision instrumentation and test solutions designed for the semiconductor, microelectronics and related manufacturing industries. The company's offerings focus on thermal management and instrument interface technologies that support the environmental conditioning and electrical performance evaluation of devices under test. These solutions include temperature controllers and cyclers, thermal subsystems, load boards, connectors and custom test interfaces engineered to accelerate reliability testing, product qualification and high-volume production measurement.

Serving customers across North America, Europe and Asia, inTEST supports semiconductor fabs, assembly and packaging facilities, research laboratories and OEM equipment builders.

Further Reading

Earnings History and Estimates for inTEST (NYSE:INTT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines